Alamar Biosciences, Inc. — Investor Relations & Filings
Alamar Biosciences, Inc. is a commercial-stage proteomics company focused on powering precision proteomics for the earliest detection of disease. It develops and commercializes an automated, high-throughput, ultra-high sensitivity platform, including ARGO™ and NULISA™ technologies. This platform redefines protein biomarker detection by enabling the discovery of novel plasma biomarkers, even from low-volume specimens, that are often invisible with conventional immunoassays. The technology supports groundbreaking insights in biomarker discovery, drug development, and disease research, expanding applications across various conditions like Alzheimer's, TBI, and stroke, from pediatric to geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-08 | English | |
| 8-K | 2026-05-08 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Regulatory Filings 2026 | 2026-04-21 | English | |
| S-8 | 2026-04-20 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46725313 | 10-Q | 2026-05-08 | English | ||
| 46725306 | 8-K | 2026-05-08 | English | ||
| 46725314 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725315 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725316 | Regulatory Filings 2026 | 2026-04-21 | English | ||
| 46725319 | S-8 | 2026-04-20 | English | ||
| 46725321 | 8-K | 2026-04-20 | English | ||
| 46725323 | POS AM | 2026-04-20 | English | ||
| 46725325 | 424B4 | 2026-04-17 | English | ||
| 46725326 | Regulatory Filings 2026 | 2026-04-17 | English | ||
| 46725329 | S-1MEF | 2026-04-17 | English | ||
| 46725328 | Regulatory Filings 2026 | 2026-04-16 | English | ||
| 46725327 | S-1/A | 2026-04-16 | English | ||
| 46725330 | 8-A12B | 2026-04-15 | English | ||
| 46725336 | S-1/A | 2026-04-13 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
curacle co., ltd.
A clinical-stage biopharma developing drugs for intractable…
|
365270 | KR | Professional, scientific and te… |
|
CVR Medical Corp.
Med-tech developing non-invasive diagnostics using sound wa…
|
CRRVF | CA | Professional, scientific and te… |
|
CYNATA THERAPEUTICS LIMITED
Develops regenerative medicine therapies using iPSC-derived…
|
CYP | AU | Professional, scientific and te… |
|
CytoMed Therapeutics Ltd
Clinical-stage developer of off-the-shelf allogeneic cell i…
|
GDTC | SG | Professional, scientific and te… |
|
Cytophage Technologies Ltd.
Creates tailor-made synthetic phages to prevent and treat b…
|
CYTO | CA | Professional, scientific and te… |
|
Cyxone AB
A clinical-stage biotech developing therapies for autoimmun…
|
CYXO | SE | Professional, scientific and te… |
|
DARWIN AG
Biotechnology firm creating personalized products from indi…
|
7V0 | DE | Professional, scientific and te… |
|
DEINOVE
Develops compounds from rare bacteria for cosmetics and new…
|
ALDEI | FR | Professional, scientific and te… |
|
Delta Drone
Develops drone-based systems for the logistics, security, a…
|
ALDR | FR | Professional, scientific and te… |
|
Delta-Fly Pharma, Inc.
Biopharmaceutical firm developing novel anticancer drugs fr…
|
4598 | JP | Professional, scientific and te… |
Alamar Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72612/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72612 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72612 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72612 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72612}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alamar Biosciences, Inc. (id: 72612)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.